Bluesky Facebook Reddit Email

Lactic acid and lactylation in the progression of pulmonary fibrosis

05.27.26 | Compuscript Ltd

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2026-0009

Announcing a new article publication in BIO Integration . Pulmonary fibrosis (PF) is a progressive and irreversible interstitial lung disease that is characterized by destruction of alveolar architecture, excessive proliferation of fibroblasts, and aberrant deposition of extracellular matrix (ECM) but the precise pathogenesis has yet to be fully elucidated. Although traditionally regarded as the terminal metabolite of glycolysis, lactate has been reappreciated, especially following the rise of metabolic reprogramming concepts after the Warburg effect, as an important signaling molecule capable of actively regulating diverse cellular functions. Among these cellular functions, the lactate-induced post-translational modification (PTM), known as lactylation, offers a new perspective for understanding the broad biological actions of lactate beyond metabolism. Notably, the pathologic microenvironment of PF is characterized by widespread metabolic reprogramming and lactate accumulation, suggesting that lactate and lactate-mediated lactylation may serve key roles in disease progression by regulating pro-fibrotic gene expression and influencing fibroblast activation and differentiation. This review article focuses on how lactylation functions as a bridge linking metabolic reprogramming to fibrotic phenotypes in PF and the translational potential as a novel therapeutic target is discussed.

# # # # # #

BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

Please visit www.bio-integration.org to learn more about the journal.

Editorial Board: https://bio-integration.org/editorial-board/

BIOI is available on the ScienceOpen platform ( https://www.scienceopen.com/search#collection/55f45bac-fd64-431c-9fe7-50fd6a7f8781 ).

Submissions may be made using ScholarOne ( https://mc04.manuscriptcentral.com/bioi ).

There are no author submission or article processing fees.

Follow BIOI on Twitter @JournalBio ; Facebook ( https://www.facebook.com/BIO-Integration-Journal-108140854107716/ ) and LinkedIn ( https://www.linkedin.com/company/bio-integration-journal/ ).

ISSN 2712-0074

eISSN 2712-0082

Fengxu Wang, Mengna Jiang and Li Zhu et al. Lactic acid and Lactylation in the Progression of Pulmonary Fibrosis. BIOI. 2026. Vol. 7(1). DOI: 10.15212/bioi-2026-0009

10.15212/bioi-2026-0009

Keywords

Article Information

Contact Information

Conor Lovett
Compuscript Ltd
c.lovett@cvia-journal.org

How to Cite This Article

APA:
Compuscript Ltd. (2026, May 27). Lactic acid and lactylation in the progression of pulmonary fibrosis. Brightsurf News. https://www.brightsurf.com/news/LKNO79GL/lactic-acid-and-lactylation-in-the-progression-of-pulmonary-fibrosis.html
MLA:
"Lactic acid and lactylation in the progression of pulmonary fibrosis." Brightsurf News, May. 27 2026, https://www.brightsurf.com/news/LKNO79GL/lactic-acid-and-lactylation-in-the-progression-of-pulmonary-fibrosis.html.